Precigen, Inc. P/E ratio

P/E ratio of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/E ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its earnings per share. A low P/E ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/E ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current P/E ratio of Precigen, Inc. is 12.33 (as of December 31, 2022)
  • P/E ratio for the quarter ending December 31, 2022 was 12.33 (a -30.19% decrease compared to previous quarter)
  • Year-over-year quarterly P/E ratio increased by Infinity%
  • Annual P/E ratio for 2022 was 12.33 (a Infinity% increase from previous year)
  • Annual P/E ratio for 2021 was 0.0 (a NaN% decrease from previous year)
  • Annual P/E ratio for 2020 was 0.0 (a NaN% decrease from previous year)
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/E ratio of Precigen, Inc.

Most recent P/E ratioof PGEN including historical data for past 10 years.

Interactive Chart of P/E ratio of Precigen, Inc.

Precigen, Inc. P/E ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 12.33 17.67 0.0 0.0 12.33
2021 0.0 0.0 0.0 0.0 0.0
2020 0.0 0.0 0.0 0.0 0.0
2019 0.0 0.0 0.0 0.0 0.0
2018 0.0 0.0 0.0 0.0 0.0
2017 0.0 0.0 0.0 0.0 0.0
2016 0.0 0.0 0.0 0.0 0.0
2015 0.0 0.0 0.0 0.0 0.0
2014 0.0 0.0 0.0 0.0 0.0
2013 0.0 0.0 0.0 0.0 0.0
2012 0.0 0.0 – – 0.0

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com